Back to search

Article

Classes of ITD predict outcomes in patients with AML treated with <i>FLT3</i> inhibitors

2018-05-14

Abstract excerpt

Recurrent internal tandem duplication (ITD) mutations are observed in various cancers including acute myeloid leukemia (AML). ITD mutations of Fms-like tyrosine kinase 3 ( FLT3 ) receptor increase kinase activity, and are associated with poor prognostic outcomes. Currently, several small-molecule FLT3 inhibitors (FLT3i) are in clinical trials for targeted therapy of high-risk FLT3-ITD-positive AML. However, the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
031cb267-8fba-56f8-b9c3-cb2de0ed04fc
DOI
10.1101/322354
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Classes of ITD predict outcomes in patients with AML treated with <i>FLT3</i> inhibitorsDOI 10.1101/322354
Select a neighboring publication to make it the new centre.